Skip to main content
Erschienen in: International Urogynecology Journal 2/2008

01.02.2008 | Original Article

Partial colpocleisis for the treatment of sacrocolpopexy mesh erosions

verfasst von: Lieschen H. Quiroz, Robert E. Gutman, Matthew J. Fagan, Geoffrey W. Cundiff

Erschienen in: International Urogynecology Journal | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study is to describe the outcomes of partial colpocleisis for mesh erosions after sacrocolpopexy. We retrospectively report our surgical management of mesh erosion after sacrocolpopexy. Between 1998 and 2006, we performed 499 sacral colpopexies and treated 21 patients for mesh erosion, including three referrals. Mean (range) time to diagnosis was 10.3 months (1–49). Grafts materials included: Mersilene (13), Prolene (7), and Pelvicol (1). Surgical outcomes were available for 19 patients. Ten (48%) patients were cured by the initial partial colpocleisis, while nine (45%) required a second or third (2, 10%) vaginal operation. All of the second and third vaginal excisions failed. Eight patients had an abdominal excision, and two patients required a second abdominal procedure. The success rate for the first and second abdominal resections was 38% (3/8) and 100% (2/2). Abdominal surgeries had higher blood loss (84 vs 378 cc, p = 0.012) longer hospitalization (outpatient vs 4.2 days p = 0.001), and additional morbidity (18.6%). Potential contributing factors to surgical failure were the presence of Actinomyces and current smoking. We recommend initial transvaginal mesh resection with partial colpocleisis for synthetic mesh erosions after sacrocolpopexy. Vaginal failures may be better served by an abdominal excision. Potential contributors to failure include current smoking and the presence of Actinomyces.
Literatur
1.
Zurück zum Zitat Nygaard IE, McCreery R, Brubaker L, Connolly A, Cundiff G, Weber AM, Zyczynski H (2004) Pelvic Floor Disorders Network. Abdominal sacrocolpopexy: a comprehensive review. Obstet Gynecol 104:805–823PubMed Nygaard IE, McCreery R, Brubaker L, Connolly A, Cundiff G, Weber AM, Zyczynski H (2004) Pelvic Floor Disorders Network. Abdominal sacrocolpopexy: a comprehensive review. Obstet Gynecol 104:805–823PubMed
2.
Zurück zum Zitat Visco AG, Weidner AC, Barber MD, Myers ER, Cundiff GW, Bump RC, Addison WA (2001) Vaginal mesh erosion after abdominal sacral colpopexy. Am J Obstet Gynecol 184:297–302PubMedCrossRef Visco AG, Weidner AC, Barber MD, Myers ER, Cundiff GW, Bump RC, Addison WA (2001) Vaginal mesh erosion after abdominal sacral colpopexy. Am J Obstet Gynecol 184:297–302PubMedCrossRef
3.
Zurück zum Zitat Begley JS, Kupferman SP, Kuznetsov DD, Kobashi KC, Govier FE, McGonigle KF, Muntz HG (2005) Incidence and management of abdominal sacrocolpopexy mesh erosions. Am J Obstet Gynecol 192:1956–1962PubMedCrossRef Begley JS, Kupferman SP, Kuznetsov DD, Kobashi KC, Govier FE, McGonigle KF, Muntz HG (2005) Incidence and management of abdominal sacrocolpopexy mesh erosions. Am J Obstet Gynecol 192:1956–1962PubMedCrossRef
4.
Zurück zum Zitat Hopkins MP, Rooney C (2004) Entero mesh vaginal fistula secondary to abdominal sacral colpopexy. Obstet Gynecol 103:1035–1036PubMed Hopkins MP, Rooney C (2004) Entero mesh vaginal fistula secondary to abdominal sacral colpopexy. Obstet Gynecol 103:1035–1036PubMed
5.
Zurück zum Zitat Hart SR, Weiser EB (2004) Abdominal sacral colpopexy mesh erosion resulting in a sinus tract formation and sacral abscess. Obstet Gynecol 103:1037–1040PubMed Hart SR, Weiser EB (2004) Abdominal sacral colpopexy mesh erosion resulting in a sinus tract formation and sacral abscess. Obstet Gynecol 103:1037–1040PubMed
6.
Zurück zum Zitat Mattox TF, Stanford EJ, Varner E (2004) Infected abdominal sacrocolpopexies: diagnosis and treatment. Int Urogynecol J Pelvic Floor Dysfunct 15:319–323PubMed Mattox TF, Stanford EJ, Varner E (2004) Infected abdominal sacrocolpopexies: diagnosis and treatment. Int Urogynecol J Pelvic Floor Dysfunct 15:319–323PubMed
7.
Zurück zum Zitat Addison WA, Cundiff GW, Bump RC, Harris RL (1996) Sacral colpopexy is the preferred treatment for vaginal vault prolapse. J Gynecol Tech 2:69–74 Addison WA, Cundiff GW, Bump RC, Harris RL (1996) Sacral colpopexy is the preferred treatment for vaginal vault prolapse. J Gynecol Tech 2:69–74
8.
Zurück zum Zitat Cundiff GW, Harris RL, Coates K, Low VH, Bump RC, Addison WA (1997) Abdominal sacral colpoperineopexy: a new approach for correction of posterior compartment defects and perineal descent associated with vaginal vault prolapse. Am J Obstet Gynecol 177:1345–53; discussion 1353–5PubMedCrossRef Cundiff GW, Harris RL, Coates K, Low VH, Bump RC, Addison WA (1997) Abdominal sacral colpoperineopexy: a new approach for correction of posterior compartment defects and perineal descent associated with vaginal vault prolapse. Am J Obstet Gynecol 177:1345–53; discussion 1353–5PubMedCrossRef
9.
Zurück zum Zitat Romero AA, Amundsen CL, Weidner AC, Webster GD (2004) Transvaginal endoscopic removal of eroded mesh after abdominal sacral colpopexy. Obstet Gynecol 103:1040–1042PubMed Romero AA, Amundsen CL, Weidner AC, Webster GD (2004) Transvaginal endoscopic removal of eroded mesh after abdominal sacral colpopexy. Obstet Gynecol 103:1040–1042PubMed
10.
Zurück zum Zitat Taylor GB, Moore RD, Miklos JR (2006) Osteomyelitis secondary to sacral colpopexy mesh erosion requiring laminectomy. Obstet Gynecol 107:475–477PubMed Taylor GB, Moore RD, Miklos JR (2006) Osteomyelitis secondary to sacral colpopexy mesh erosion requiring laminectomy. Obstet Gynecol 107:475–477PubMed
11.
Zurück zum Zitat Kohli N, Walsh PM, Roat TW, Karram MM (1998) Mesh erosion after abdominal sacrocolpopexy. Obstet Gynecol 92:999–1004PubMedCrossRef Kohli N, Walsh PM, Roat TW, Karram MM (1998) Mesh erosion after abdominal sacrocolpopexy. Obstet Gynecol 92:999–1004PubMedCrossRef
12.
Zurück zum Zitat Schettini M, Fortunato P, Gallucci M (1999) Abdominal sacral colpopexy with prolene mesh. Int Urogynecol J Pelvic Floor Dysfunct 10:295–299PubMedCrossRef Schettini M, Fortunato P, Gallucci M (1999) Abdominal sacral colpopexy with prolene mesh. Int Urogynecol J Pelvic Floor Dysfunct 10:295–299PubMedCrossRef
13.
Zurück zum Zitat Limb J, Wood K, Weinberger M, Miyazaki F, Aboseif S (2005) Sacral colpopexy using mersilene mesh in the treatment of vaginal vault prolapse. World J Urol 23:55–60PubMedCrossRef Limb J, Wood K, Weinberger M, Miyazaki F, Aboseif S (2005) Sacral colpopexy using mersilene mesh in the treatment of vaginal vault prolapse. World J Urol 23:55–60PubMedCrossRef
14.
Zurück zum Zitat Diana M, Zoppe C, Mastrangeli B (2000) Treatment of vaginal vault prolapse with abdominal sacral colpopexy using prolene mesh. Am J Surg 179:126–128PubMedCrossRef Diana M, Zoppe C, Mastrangeli B (2000) Treatment of vaginal vault prolapse with abdominal sacral colpopexy using prolene mesh. Am J Surg 179:126–128PubMedCrossRef
15.
Zurück zum Zitat Amid PK, Shulman AG, Lichtenstein IL, Hakakha M (1994) Biomaterials for abdominal wall hernia surgery and principles of their applications. Langenbecks Arch Chir 379:168–171PubMedCrossRef Amid PK, Shulman AG, Lichtenstein IL, Hakakha M (1994) Biomaterials for abdominal wall hernia surgery and principles of their applications. Langenbecks Arch Chir 379:168–171PubMedCrossRef
16.
Zurück zum Zitat Wu JM, Wells EC, Hundley AF, Connolly A, Williams KS, Visco AG (2006) Mesh erosion in abdominal sacral colpopexy with and without concomitant hysterectomy. Am J Obstet Gynecol 194:1418–1422PubMedCrossRef Wu JM, Wells EC, Hundley AF, Connolly A, Williams KS, Visco AG (2006) Mesh erosion in abdominal sacral colpopexy with and without concomitant hysterectomy. Am J Obstet Gynecol 194:1418–1422PubMedCrossRef
17.
Zurück zum Zitat Culligan PJ, Murphy M, Blackwell L, Hammons G, Graham C, Heit MH (2002) Long-term success of abdominal sacral colpopexy using synthetic mesh. Am J Obstet Gynecol 187:1473–1480; discussion 1481–2PubMedCrossRef Culligan PJ, Murphy M, Blackwell L, Hammons G, Graham C, Heit MH (2002) Long-term success of abdominal sacral colpopexy using synthetic mesh. Am J Obstet Gynecol 187:1473–1480; discussion 1481–2PubMedCrossRef
18.
Zurück zum Zitat Brizzolara S, Pillai-Allen A (2003) Risk of mesh erosion with sacral colpopexy and concurrent hysterectomy. Obstet Gynecol 102:306–310PubMedCrossRef Brizzolara S, Pillai-Allen A (2003) Risk of mesh erosion with sacral colpopexy and concurrent hysterectomy. Obstet Gynecol 102:306–310PubMedCrossRef
19.
Zurück zum Zitat Jorgensen LN, Kallehave F, Christensen E, Siana JE, Gottrup F (1998) Less collagen production in smokers. Surgery 123:450–455PubMed Jorgensen LN, Kallehave F, Christensen E, Siana JE, Gottrup F (1998) Less collagen production in smokers. Surgery 123:450–455PubMed
20.
Zurück zum Zitat Sorensen LT, Hemmingsen UB, Kirkeby LT, Kallehave F, Jorgensen LN (2005) Smoking is a risk factor for incisional hernia. Arch Surg 140:119–123PubMedCrossRef Sorensen LT, Hemmingsen UB, Kirkeby LT, Kallehave F, Jorgensen LN (2005) Smoking is a risk factor for incisional hernia. Arch Surg 140:119–123PubMedCrossRef
Metadaten
Titel
Partial colpocleisis for the treatment of sacrocolpopexy mesh erosions
verfasst von
Lieschen H. Quiroz
Robert E. Gutman
Matthew J. Fagan
Geoffrey W. Cundiff
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 2/2008
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-007-0416-7

Weitere Artikel der Ausgabe 2/2008

International Urogynecology Journal 2/2008 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.